2011-002349-36
Taste Assessment of Maxalt Oral Disintegrating Tablets in Children
Merck & Co., Inc.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Migraine
Sponsor & location
- Primary sponsor
- Merck & Co., Inc.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
a. Subject or parent/legal guardian, is, in the opinion of the investigator, mentally incapacitated.
ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2011-002349-36
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2011-002349-36 through Pure Global AI's free database. This phase not specified trial is sponsored by Merck & Co., Inc. and is currently status unknown. The study focuses on Migraine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.